Eudaimonia Asset Management »

Immix Biopharma shares owned by Eudaimonia Asset Management

Quarter-by-quarter ownership of Immix Biopharma (IMMX) shares owned by Eudaimonia Asset Management from 13F filings

Historical chart of Eudaimonia Asset Management investment in Immix Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Immix Biopharma held by Eudaimonia Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Immix Biopharma by Eudaimonia Asset Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $632k 121k 5.23

More positions owned by Eudaimonia Asset Management

Credo Technology Group Holding Common Stock (CRDO)
Advanced Energy Industries Common Stock (AEIS)
nLight Common Stock (LASR)
Fabrinet Common Stock (FN)
TTM Technologies Common Stock (TTMI)
Madrigal Pharmaceuticals Common Stock (MDGL)
Bridgebio Pharma Common Stock (BBIO)
Guardant Health Common Stock (GH)
Dycom Industries Common Stock (DY)
Sanmina Corp Common Stock (SANM)
Zurn Elkay Water Solutions Corp Common Stock (ZWS)
Hecla Mining Common Stock (HL)
Turning Point Brands Common Stock (TPB)
Blackrock Funds - Equities ETF (SMIN)
Protagonist Therapeutics Common Stock (PTGX)

View all positions for Eudaimonia Asset Management

Top funds holding Immix Biopharma

Marshall Wace
Vanguard Group
Logos Global Management
Franklin Resources
Bleichroeder
Renaissance Technologies
Geode Capital Management
KVP Capital Advisors
Goldman Sachs Group
Eudaimonia Asset Management
Bank of New York Mellon
State Street Corporation
Susquehanna International
Citadel Advisors
Northern Trust

View all funds holding Immix Biopharma